Non-drug evidence map · Rehabilitation and therapy services

Multidisciplinary and other rehabilitation

512 registered trials across 65 conditions, from ClinicalTrials.gov.

  1. Research Tracker
  2. Non-drug evidence map
  3. Multidisciplinary and other rehabilitation

Rehabilitation programmes, including occupational, speech and multidisciplinary care. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

512registered trials
65conditions
176completed
7with results posted
121recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Multiple Sclerosis
Show trials
6118 015 56300
Ischemic Stroke
Show trials
4817 07 43405
Parkinson Disease
Show trials
4112 113 29480
Low Back Pain
Show trials
298 014 26480
Osteoarthritis
Show trials
2910 09 27500
Long COVID
Show trials
2411 10 17460
Heart Failure
Show trials
236 09 19880
Cervical Cancer
Show trials
183 09 6650
Sarcopenia
Show trials
184 15 11750
Lung Cancer
Show trials
156 17 12868
Peripheral Arterial Disease
Show trials
125 01 6300
Fibromyalgia
Show trials
117 11 6300
Pancreatic Cancer
Show trials
113 03 4245
Pulmonary Arterial Hypertension
Show trials
112 05 9104
Schizophrenia
Show trials
114 04 10330
Attention Deficit-Hyperactivity Disorder
Show trials
108 00 650
Carpal Tunnel Syndrome
Show trials
105 01 9178
Chronic Obstructive Pulmonary Disease
Show trials
103 23 8200
Ovarian Cancer
Show trials
102 03 5225
Obstructive Sleep Apnea
Show trials
94 00 7180
Prostate Cancer
Show trials
94 04 5224
Cancer
Show trials
81 04 6238
Epilepsy
Show trials
82 02 5214
Atrial Fibrillation
Show trials
71 01 6520
Bladder Cancer
Show trials
72 03 4224
Colorectal Cancer
Show trials
73 02 5180
Obesity
Show trials
74 02 250
Rheumatoid Arthritis
Show trials
74 00 7242
Diabetic Neuropathy
Show trials
63 02 5119
Gastroesophageal Reflux Disease
Show trials
60 00 680
Osteoporosis
Show trials
63 00 42,150
Breast Cancer
Show trials
53 01 2110
HIV/AIDS
Show trials
51 03 2650
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Show trials
52 01 380
Amyotrophic Lateral Sclerosis
Show trials
41 01 480
Asthma
Show trials
40 01 3110
Bipolar Disorder
Show trials
41 01 4180
Chronic Kidney Disease
Show trials
41 01 3138
Endometriosis
Show trials
30 01 3126
Migraine Disorder
Show trials
31 02 3195
Opioid Use Disorder
Show trials
31 01 3100
Cystic Fibrosis
Show trials
21 00 230
Multiple Myeloma
Show trials
20 00 167
Sepsis
Show trials
20 00 21,600
Type 2 Diabetes Mellitus
Show trials
21 00 2713
Age-Related Macular Degeneration
Show trials
10 00 038
Alcohol Abuse
Show trials
11 00 11,211
Ankylosing Spondylitis
Show trials
11 00 1242
Anxiety
Show trials
10 00 00
Glaucoma
Show trials
10 00 1100
Hepatitis C
Show trials
10 00 030
Huntington Disease
Show trials
11 00 164
Inflammatory Bowel Disease
Show trials
10 00 190
Interstitial Cystitis
Show trials
10 00 00
Melanoma
Show trials
  • CARE-Melanoma Trial Not yet recruiting NCT07320222 · started 2026 · 30 participants · randomised · Phase 1
10 00 130
Metabolic Dysfunction-Associated Steatohepatitis
Show trials
11 00 124
Non-Hodgkin Lymphoma
Show trials
10 00 024
Overactive Bladder
Show trials
11 00 1100
Polycystic Ovary Syndrome
Show trials
10 00 133
Psoriatic Arthritis
Show trials
10 00 135
Sickle Cell Disease
Show trials
10 01 0198
Sjögren's Syndrome
Show trials
10 00 136
Systemic Lupus Erythematosus
Show trials
11 00 1242
Tinnitus
Show trials
10 00 174
Type 1 Diabetes Mellitus
Show trials
10 00 116

What these trials measure

Primary outcomes, grouped by keyword rules: Physical function and exercise capacity (178), Feasibility, adherence and safety (107), Symptom severity and disease activity (75), Pain (66), Cognition (61), Quality of life (55), Clinical events, survival and healthcare use (42), Mood, anxiety and wellbeing (40), Inflammation and other biomarkers (28), Breathing and lung function (21), Weight and metabolic markers (18), Fatigue and energy (15), Heart rate, blood pressure and autonomic (14), Sleep (13), Post-exertional symptoms (1).

Names used for this class in the registry

telerehabilitation, rehabilitation, conventional rehabilitation, prehabilitation, cognitive rehabilitation, multimodal prehabilitation, rehabilitation therapy, prehabilitation program, cardiac rehabilitation, standard rehabilitation, rehabilitation training, occupational therapy

Download all 512 trials (CSV) All non-drug classes

Related in Rehabilitation and therapy services: Physiotherapy and physical therapy

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.